Five-Year Survival and Correlates among Patients with Advanced Melanoma, Renal Cell Carcinoma, or Non-Small Cell Lung Cancer Treated with Nivolumab.
Times cited: 21
Nivolumab in patients with relapsed or refractory hematologic malignancy: Preliminary results of a phase ib study.
Journal of Clinical Oncology.
Times cited: 394
PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma.
New England Journal of Medicine.
Times cited: 1819